AstraZeneca (AZN.L) Stock News & Analysis

AstraZeneca share price: $18.5 billion China obesity-drug deal puts AZN stock in focus for Monday

AstraZeneca PLC shares climbed on Friday after the drugmaker struck a deal to license obesity and weight management drug candidates from CSPC Pharmaceutical Group, in a pact valued at up to $18.5 billion. CSPC revealed AstraZeneca would pay $1.2 billion upfront, with an additional $17.3 billion contingent on meeting milestones. Tony Ren of Macquarie Capital described the move as a “buy the rumour, sell the news” play, after CSPC’s shares dropped nearly 12% in Hong Kong.

GSK share price slips in early London trade as tariff jitters flare — what investors watch next

Shares of GSK plc edged down 0.6% to 1,806 pence by 0802 GMT, marking a subdued opening for the drugmaker in London. The stock fluctuated between 1,796p and 1,809p, staying far from its 52-week peak.

19 January 2026

LSE:AZN.L·LSE:GSK.L·Stock Market

Best UK Stocks to Buy Today (8 December 2025): 7 FTSE 100 Ideas for a Potential Rate‑Cut Era

The UK stock market has quietly turned into one of 2025’s star performers. The FTSE 100 is trading around 9,660 and has delivered a total return of roughly 20–23% year‑to‑date, one of its best years since the aftermath of the financial crisis.Investors Chronicle+2Wealth DFM+2

8 December 2025